nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000604	0.000604	CcSEcCtD
Valganciclovir—Cough—Docetaxel—pancreatic cancer	0.000604	0.000604	CcSEcCtD
Valganciclovir—Hypersensitivity—Irinotecan—pancreatic cancer	0.000602	0.000602	CcSEcCtD
Valganciclovir—Pneumonia—Epirubicin—pancreatic cancer	0.000601	0.000601	CcSEcCtD
Valganciclovir—Convulsion—Docetaxel—pancreatic cancer	0.000599	0.000599	CcSEcCtD
Valganciclovir—Hypertension—Docetaxel—pancreatic cancer	0.000597	0.000597	CcSEcCtD
Valganciclovir—Infestation NOS—Epirubicin—pancreatic cancer	0.000597	0.000597	CcSEcCtD
Valganciclovir—Infestation—Epirubicin—pancreatic cancer	0.000597	0.000597	CcSEcCtD
Valganciclovir—Bronchitis—Doxorubicin—pancreatic cancer	0.000596	0.000596	CcSEcCtD
Valganciclovir—Arthralgia—Docetaxel—pancreatic cancer	0.000589	0.000589	CcSEcCtD
Valganciclovir—Nausea—Sunitinib—pancreatic cancer	0.000589	0.000589	CcSEcCtD
Valganciclovir—Pancytopenia—Doxorubicin—pancreatic cancer	0.000589	0.000589	CcSEcCtD
Valganciclovir—Renal failure—Epirubicin—pancreatic cancer	0.000587	0.000587	CcSEcCtD
Valganciclovir—Asthenia—Irinotecan—pancreatic cancer	0.000586	0.000586	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000585	0.000585	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000585	0.000585	CcSEcCtD
Valganciclovir—Jaundice—Epirubicin—pancreatic cancer	0.000582	0.000582	CcSEcCtD
Valganciclovir—Stomatitis—Epirubicin—pancreatic cancer	0.000582	0.000582	CcSEcCtD
Valganciclovir—Urinary tract infection—Epirubicin—pancreatic cancer	0.00058	0.00058	CcSEcCtD
Valganciclovir—Dysuria—Doxorubicin—pancreatic cancer	0.00058	0.00058	CcSEcCtD
Valganciclovir—Neutropenia—Doxorubicin—pancreatic cancer	0.00058	0.00058	CcSEcCtD
Valganciclovir—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000576	0.000576	CcSEcCtD
Valganciclovir—Dry mouth—Docetaxel—pancreatic cancer	0.000576	0.000576	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000576	0.000576	CcSEcCtD
Valganciclovir—Pollakiuria—Doxorubicin—pancreatic cancer	0.000573	0.000573	CcSEcCtD
Valganciclovir—Asthenia—Gemcitabine—pancreatic cancer	0.000571	0.000571	CcSEcCtD
Valganciclovir—Haematuria—Epirubicin—pancreatic cancer	0.000569	0.000569	CcSEcCtD
Valganciclovir—Confusional state—Docetaxel—pancreatic cancer	0.000569	0.000569	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000566	0.000566	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000565	0.000565	CcSEcCtD
Valganciclovir—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000565	0.000565	CcSEcCtD
Valganciclovir—Oedema—Docetaxel—pancreatic cancer	0.000565	0.000565	CcSEcCtD
Valganciclovir—Pruritus—Gemcitabine—pancreatic cancer	0.000563	0.000563	CcSEcCtD
Valganciclovir—Infection—Docetaxel—pancreatic cancer	0.000561	0.000561	CcSEcCtD
Valganciclovir—Weight decreased—Doxorubicin—pancreatic cancer	0.000561	0.000561	CcSEcCtD
Valganciclovir—Sinusitis—Epirubicin—pancreatic cancer	0.00056	0.00056	CcSEcCtD
Valganciclovir—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000559	0.000559	CcSEcCtD
Valganciclovir—Diarrhoea—Irinotecan—pancreatic cancer	0.000559	0.000559	CcSEcCtD
Valganciclovir—Pneumonia—Doxorubicin—pancreatic cancer	0.000556	0.000556	CcSEcCtD
Valganciclovir—Nervous system disorder—Docetaxel—pancreatic cancer	0.000554	0.000554	CcSEcCtD
Valganciclovir—Pruritus—Fluorouracil—pancreatic cancer	0.000554	0.000554	CcSEcCtD
Valganciclovir—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000553	0.000553	CcSEcCtD
Valganciclovir—Infestation—Doxorubicin—pancreatic cancer	0.000553	0.000553	CcSEcCtD
Valganciclovir—Infestation NOS—Doxorubicin—pancreatic cancer	0.000553	0.000553	CcSEcCtD
Valganciclovir—Tachycardia—Docetaxel—pancreatic cancer	0.000551	0.000551	CcSEcCtD
Valganciclovir—Skin disorder—Docetaxel—pancreatic cancer	0.000548	0.000548	CcSEcCtD
Valganciclovir—Diarrhoea—Gemcitabine—pancreatic cancer	0.000544	0.000544	CcSEcCtD
Valganciclovir—Renal failure—Doxorubicin—pancreatic cancer	0.000543	0.000543	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000542	0.000542	CcSEcCtD
Valganciclovir—Dizziness—Irinotecan—pancreatic cancer	0.00054	0.00054	CcSEcCtD
Valganciclovir—Haemoglobin—Epirubicin—pancreatic cancer	0.000539	0.000539	CcSEcCtD
Valganciclovir—Stomatitis—Doxorubicin—pancreatic cancer	0.000539	0.000539	CcSEcCtD
Valganciclovir—Jaundice—Doxorubicin—pancreatic cancer	0.000539	0.000539	CcSEcCtD
Valganciclovir—Anorexia—Docetaxel—pancreatic cancer	0.000538	0.000538	CcSEcCtD
Valganciclovir—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000537	0.000537	CcSEcCtD
Valganciclovir—Hepatitis—Epirubicin—pancreatic cancer	0.000536	0.000536	CcSEcCtD
Valganciclovir—Haemorrhage—Epirubicin—pancreatic cancer	0.000536	0.000536	CcSEcCtD
Valganciclovir—Diarrhoea—Fluorouracil—pancreatic cancer	0.000535	0.000535	CcSEcCtD
Valganciclovir—Pharyngitis—Epirubicin—pancreatic cancer	0.000532	0.000532	CcSEcCtD
Valganciclovir—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000529	0.000529	CcSEcCtD
Valganciclovir—Oedema peripheral—Epirubicin—pancreatic cancer	0.000528	0.000528	CcSEcCtD
Valganciclovir—Hypotension—Docetaxel—pancreatic cancer	0.000528	0.000528	CcSEcCtD
Valganciclovir—Haematuria—Doxorubicin—pancreatic cancer	0.000527	0.000527	CcSEcCtD
Valganciclovir—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000527	0.000527	CcSEcCtD
Valganciclovir—Urethral disorder—Epirubicin—pancreatic cancer	0.000526	0.000526	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000523	0.000523	CcSEcCtD
Valganciclovir—Vomiting—Irinotecan—pancreatic cancer	0.000519	0.000519	CcSEcCtD
Valganciclovir—Sinusitis—Doxorubicin—pancreatic cancer	0.000518	0.000518	CcSEcCtD
Valganciclovir—Dizziness—Fluorouracil—pancreatic cancer	0.000517	0.000517	CcSEcCtD
Valganciclovir—Visual impairment—Epirubicin—pancreatic cancer	0.000517	0.000517	CcSEcCtD
Valganciclovir—Dermatitis—Irinotecan—pancreatic cancer	0.000515	0.000515	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000514	0.000514	CcSEcCtD
Valganciclovir—Headache—Irinotecan—pancreatic cancer	0.000512	0.000512	CcSEcCtD
Valganciclovir—Insomnia—Docetaxel—pancreatic cancer	0.000511	0.000511	CcSEcCtD
Valganciclovir—Paraesthesia—Docetaxel—pancreatic cancer	0.000507	0.000507	CcSEcCtD
Valganciclovir—Vomiting—Gemcitabine—pancreatic cancer	0.000506	0.000506	CcSEcCtD
Valganciclovir—Dyspnoea—Docetaxel—pancreatic cancer	0.000503	0.000503	CcSEcCtD
Valganciclovir—Somnolence—Docetaxel—pancreatic cancer	0.000502	0.000502	CcSEcCtD
Valganciclovir—Dermatitis—Gemcitabine—pancreatic cancer	0.000501	0.000501	CcSEcCtD
Valganciclovir—Eye disorder—Epirubicin—pancreatic cancer	0.000501	0.000501	CcSEcCtD
Valganciclovir—Tinnitus—Epirubicin—pancreatic cancer	0.0005	0.0005	CcSEcCtD
Valganciclovir—Haemoglobin—Doxorubicin—pancreatic cancer	0.000499	0.000499	CcSEcCtD
Valganciclovir—Headache—Gemcitabine—pancreatic cancer	0.000498	0.000498	CcSEcCtD
Valganciclovir—Cardiac disorder—Epirubicin—pancreatic cancer	0.000498	0.000498	CcSEcCtD
Valganciclovir—Vomiting—Fluorouracil—pancreatic cancer	0.000497	0.000497	CcSEcCtD
Valganciclovir—Dyspepsia—Docetaxel—pancreatic cancer	0.000497	0.000497	CcSEcCtD
Valganciclovir—Haemorrhage—Doxorubicin—pancreatic cancer	0.000496	0.000496	CcSEcCtD
Valganciclovir—Hepatitis—Doxorubicin—pancreatic cancer	0.000496	0.000496	CcSEcCtD
Valganciclovir—Dermatitis—Fluorouracil—pancreatic cancer	0.000493	0.000493	CcSEcCtD
Valganciclovir—Pharyngitis—Doxorubicin—pancreatic cancer	0.000492	0.000492	CcSEcCtD
Valganciclovir—Decreased appetite—Docetaxel—pancreatic cancer	0.000491	0.000491	CcSEcCtD
Valganciclovir—Headache—Fluorouracil—pancreatic cancer	0.00049	0.00049	CcSEcCtD
Valganciclovir—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00049	0.00049	CcSEcCtD
Valganciclovir—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000489	0.000489	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000488	0.000488	CcSEcCtD
Valganciclovir—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000487	0.000487	CcSEcCtD
Valganciclovir—Fatigue—Docetaxel—pancreatic cancer	0.000487	0.000487	CcSEcCtD
Valganciclovir—Angiopathy—Epirubicin—pancreatic cancer	0.000486	0.000486	CcSEcCtD
Valganciclovir—Urethral disorder—Doxorubicin—pancreatic cancer	0.000486	0.000486	CcSEcCtD
Valganciclovir—Nausea—Irinotecan—pancreatic cancer	0.000485	0.000485	CcSEcCtD
Valganciclovir—Immune system disorder—Epirubicin—pancreatic cancer	0.000484	0.000484	CcSEcCtD
Valganciclovir—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000483	0.000483	CcSEcCtD
Valganciclovir—Pain—Docetaxel—pancreatic cancer	0.000483	0.000483	CcSEcCtD
Valganciclovir—Constipation—Docetaxel—pancreatic cancer	0.000483	0.000483	CcSEcCtD
Valganciclovir—Chills—Epirubicin—pancreatic cancer	0.000481	0.000481	CcSEcCtD
Valganciclovir—Arrhythmia—Epirubicin—pancreatic cancer	0.000479	0.000479	CcSEcCtD
Valganciclovir—Visual impairment—Doxorubicin—pancreatic cancer	0.000478	0.000478	CcSEcCtD
Valganciclovir—Alopecia—Epirubicin—pancreatic cancer	0.000474	0.000474	CcSEcCtD
Valganciclovir—Nausea—Gemcitabine—pancreatic cancer	0.000473	0.000473	CcSEcCtD
Valganciclovir—Mental disorder—Epirubicin—pancreatic cancer	0.00047	0.00047	CcSEcCtD
Valganciclovir—Malnutrition—Epirubicin—pancreatic cancer	0.000467	0.000467	CcSEcCtD
Valganciclovir—Feeling abnormal—Docetaxel—pancreatic cancer	0.000465	0.000465	CcSEcCtD
Valganciclovir—Nausea—Fluorouracil—pancreatic cancer	0.000465	0.000465	CcSEcCtD
Valganciclovir—Eye disorder—Doxorubicin—pancreatic cancer	0.000464	0.000464	CcSEcCtD
Valganciclovir—Tinnitus—Doxorubicin—pancreatic cancer	0.000462	0.000462	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000462	0.000462	CcSEcCtD
Valganciclovir—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Valganciclovir—Flatulence—Epirubicin—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Valganciclovir—Tension—Epirubicin—pancreatic cancer	0.000458	0.000458	CcSEcCtD
Valganciclovir—Dysgeusia—Epirubicin—pancreatic cancer	0.000457	0.000457	CcSEcCtD
Valganciclovir—Nervousness—Epirubicin—pancreatic cancer	0.000453	0.000453	CcSEcCtD
Valganciclovir—Back pain—Epirubicin—pancreatic cancer	0.000451	0.000451	CcSEcCtD
Valganciclovir—Angiopathy—Doxorubicin—pancreatic cancer	0.00045	0.00045	CcSEcCtD
Valganciclovir—Muscle spasms—Epirubicin—pancreatic cancer	0.000449	0.000449	CcSEcCtD
Valganciclovir—Immune system disorder—Doxorubicin—pancreatic cancer	0.000448	0.000448	CcSEcCtD
Valganciclovir—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000447	0.000447	CcSEcCtD
Valganciclovir—Abdominal pain—Docetaxel—pancreatic cancer	0.000446	0.000446	CcSEcCtD
Valganciclovir—Body temperature increased—Docetaxel—pancreatic cancer	0.000446	0.000446	CcSEcCtD
Valganciclovir—Chills—Doxorubicin—pancreatic cancer	0.000445	0.000445	CcSEcCtD
Valganciclovir—Arrhythmia—Doxorubicin—pancreatic cancer	0.000443	0.000443	CcSEcCtD
Valganciclovir—Vision blurred—Epirubicin—pancreatic cancer	0.00044	0.00044	CcSEcCtD
Valganciclovir—Alopecia—Doxorubicin—pancreatic cancer	0.000438	0.000438	CcSEcCtD
Valganciclovir—Mental disorder—Doxorubicin—pancreatic cancer	0.000435	0.000435	CcSEcCtD
Valganciclovir—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000433	0.000433	CcSEcCtD
Valganciclovir—Malnutrition—Doxorubicin—pancreatic cancer	0.000432	0.000432	CcSEcCtD
Valganciclovir—Anaemia—Epirubicin—pancreatic cancer	0.000431	0.000431	CcSEcCtD
Valganciclovir—Agitation—Epirubicin—pancreatic cancer	0.000429	0.000429	CcSEcCtD
Valganciclovir—Flatulence—Doxorubicin—pancreatic cancer	0.000426	0.000426	CcSEcCtD
Valganciclovir—Tension—Doxorubicin—pancreatic cancer	0.000424	0.000424	CcSEcCtD
Valganciclovir—Dysgeusia—Doxorubicin—pancreatic cancer	0.000423	0.000423	CcSEcCtD
Valganciclovir—Malaise—Epirubicin—pancreatic cancer	0.000421	0.000421	CcSEcCtD
Valganciclovir—Nervousness—Doxorubicin—pancreatic cancer	0.000419	0.000419	CcSEcCtD
Valganciclovir—Vertigo—Epirubicin—pancreatic cancer	0.000419	0.000419	CcSEcCtD
Valganciclovir—Leukopenia—Epirubicin—pancreatic cancer	0.000418	0.000418	CcSEcCtD
Valganciclovir—Back pain—Doxorubicin—pancreatic cancer	0.000418	0.000418	CcSEcCtD
Valganciclovir—Hypersensitivity—Docetaxel—pancreatic cancer	0.000416	0.000416	CcSEcCtD
Valganciclovir—Muscle spasms—Doxorubicin—pancreatic cancer	0.000415	0.000415	CcSEcCtD
Valganciclovir—Cough—Epirubicin—pancreatic cancer	0.000407	0.000407	CcSEcCtD
Valganciclovir—Vision blurred—Doxorubicin—pancreatic cancer	0.000407	0.000407	CcSEcCtD
Valganciclovir—Asthenia—Docetaxel—pancreatic cancer	0.000405	0.000405	CcSEcCtD
Valganciclovir—Convulsion—Epirubicin—pancreatic cancer	0.000404	0.000404	CcSEcCtD
Valganciclovir—Hypertension—Epirubicin—pancreatic cancer	0.000403	0.000403	CcSEcCtD
Valganciclovir—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000401	0.000401	CcSEcCtD
Valganciclovir—Pruritus—Docetaxel—pancreatic cancer	0.0004	0.0004	CcSEcCtD
Valganciclovir—Anaemia—Doxorubicin—pancreatic cancer	0.000399	0.000399	CcSEcCtD
Valganciclovir—Arthralgia—Epirubicin—pancreatic cancer	0.000397	0.000397	CcSEcCtD
Valganciclovir—Agitation—Doxorubicin—pancreatic cancer	0.000397	0.000397	CcSEcCtD
Valganciclovir—Anxiety—Epirubicin—pancreatic cancer	0.000396	0.000396	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000395	0.000395	CcSEcCtD
Valganciclovir—Discomfort—Epirubicin—pancreatic cancer	0.000393	0.000393	CcSEcCtD
Valganciclovir—Malaise—Doxorubicin—pancreatic cancer	0.000389	0.000389	CcSEcCtD
Valganciclovir—Dry mouth—Epirubicin—pancreatic cancer	0.000389	0.000389	CcSEcCtD
Valganciclovir—Vertigo—Doxorubicin—pancreatic cancer	0.000388	0.000388	CcSEcCtD
Valganciclovir—Leukopenia—Doxorubicin—pancreatic cancer	0.000387	0.000387	CcSEcCtD
Valganciclovir—Diarrhoea—Docetaxel—pancreatic cancer	0.000386	0.000386	CcSEcCtD
Valganciclovir—Confusional state—Epirubicin—pancreatic cancer	0.000384	0.000384	CcSEcCtD
Valganciclovir—Oedema—Epirubicin—pancreatic cancer	0.000381	0.000381	CcSEcCtD
Valganciclovir—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000381	0.000381	CcSEcCtD
Valganciclovir—Infection—Epirubicin—pancreatic cancer	0.000378	0.000378	CcSEcCtD
Valganciclovir—Cough—Doxorubicin—pancreatic cancer	0.000377	0.000377	CcSEcCtD
Valganciclovir—Convulsion—Doxorubicin—pancreatic cancer	0.000374	0.000374	CcSEcCtD
Valganciclovir—Nervous system disorder—Epirubicin—pancreatic cancer	0.000374	0.000374	CcSEcCtD
Valganciclovir—Dizziness—Docetaxel—pancreatic cancer	0.000373	0.000373	CcSEcCtD
Valganciclovir—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000373	0.000373	CcSEcCtD
Valganciclovir—Hypertension—Doxorubicin—pancreatic cancer	0.000373	0.000373	CcSEcCtD
Valganciclovir—Tachycardia—Epirubicin—pancreatic cancer	0.000372	0.000372	CcSEcCtD
Valganciclovir—Skin disorder—Epirubicin—pancreatic cancer	0.00037	0.00037	CcSEcCtD
Valganciclovir—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000368	0.000368	CcSEcCtD
Valganciclovir—Arthralgia—Doxorubicin—pancreatic cancer	0.000368	0.000368	CcSEcCtD
Valganciclovir—Anxiety—Doxorubicin—pancreatic cancer	0.000366	0.000366	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000365	0.000365	CcSEcCtD
Valganciclovir—Discomfort—Doxorubicin—pancreatic cancer	0.000363	0.000363	CcSEcCtD
Valganciclovir—Anorexia—Epirubicin—pancreatic cancer	0.000363	0.000363	CcSEcCtD
Valganciclovir—Dry mouth—Doxorubicin—pancreatic cancer	0.00036	0.00036	CcSEcCtD
Valganciclovir—Vomiting—Docetaxel—pancreatic cancer	0.000359	0.000359	CcSEcCtD
Valganciclovir—Hypotension—Epirubicin—pancreatic cancer	0.000356	0.000356	CcSEcCtD
Valganciclovir—Dermatitis—Docetaxel—pancreatic cancer	0.000356	0.000356	CcSEcCtD
Valganciclovir—Confusional state—Doxorubicin—pancreatic cancer	0.000355	0.000355	CcSEcCtD
Valganciclovir—Headache—Docetaxel—pancreatic cancer	0.000354	0.000354	CcSEcCtD
Valganciclovir—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000352	0.000352	CcSEcCtD
Valganciclovir—Oedema—Doxorubicin—pancreatic cancer	0.000352	0.000352	CcSEcCtD
Valganciclovir—Infection—Doxorubicin—pancreatic cancer	0.00035	0.00035	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000347	0.000347	CcSEcCtD
Valganciclovir—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000346	0.000346	CcSEcCtD
Valganciclovir—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000345	0.000345	CcSEcCtD
Valganciclovir—Insomnia—Epirubicin—pancreatic cancer	0.000344	0.000344	CcSEcCtD
Valganciclovir—Tachycardia—Doxorubicin—pancreatic cancer	0.000344	0.000344	CcSEcCtD
Valganciclovir—Skin disorder—Doxorubicin—pancreatic cancer	0.000342	0.000342	CcSEcCtD
Valganciclovir—Paraesthesia—Epirubicin—pancreatic cancer	0.000342	0.000342	CcSEcCtD
Valganciclovir—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000341	0.000341	CcSEcCtD
Valganciclovir—Dyspnoea—Epirubicin—pancreatic cancer	0.00034	0.00034	CcSEcCtD
Valganciclovir—Somnolence—Epirubicin—pancreatic cancer	0.000339	0.000339	CcSEcCtD
Valganciclovir—Anorexia—Doxorubicin—pancreatic cancer	0.000336	0.000336	CcSEcCtD
Valganciclovir—Nausea—Docetaxel—pancreatic cancer	0.000335	0.000335	CcSEcCtD
Valganciclovir—Dyspepsia—Epirubicin—pancreatic cancer	0.000335	0.000335	CcSEcCtD
Valganciclovir—Decreased appetite—Epirubicin—pancreatic cancer	0.000331	0.000331	CcSEcCtD
Valganciclovir—Hypotension—Doxorubicin—pancreatic cancer	0.000329	0.000329	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000329	0.000329	CcSEcCtD
Valganciclovir—Fatigue—Epirubicin—pancreatic cancer	0.000328	0.000328	CcSEcCtD
Valganciclovir—Pain—Epirubicin—pancreatic cancer	0.000326	0.000326	CcSEcCtD
Valganciclovir—Constipation—Epirubicin—pancreatic cancer	0.000326	0.000326	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000321	0.000321	CcSEcCtD
Valganciclovir—Insomnia—Doxorubicin—pancreatic cancer	0.000319	0.000319	CcSEcCtD
Valganciclovir—Paraesthesia—Doxorubicin—pancreatic cancer	0.000316	0.000316	CcSEcCtD
Valganciclovir—Dyspnoea—Doxorubicin—pancreatic cancer	0.000314	0.000314	CcSEcCtD
Valganciclovir—Feeling abnormal—Epirubicin—pancreatic cancer	0.000314	0.000314	CcSEcCtD
Valganciclovir—Somnolence—Doxorubicin—pancreatic cancer	0.000313	0.000313	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000311	0.000311	CcSEcCtD
Valganciclovir—Dyspepsia—Doxorubicin—pancreatic cancer	0.00031	0.00031	CcSEcCtD
Valganciclovir—Decreased appetite—Doxorubicin—pancreatic cancer	0.000306	0.000306	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000304	0.000304	CcSEcCtD
Valganciclovir—Fatigue—Doxorubicin—pancreatic cancer	0.000304	0.000304	CcSEcCtD
Valganciclovir—Urticaria—Epirubicin—pancreatic cancer	0.000303	0.000303	CcSEcCtD
Valganciclovir—Pain—Doxorubicin—pancreatic cancer	0.000301	0.000301	CcSEcCtD
Valganciclovir—Constipation—Doxorubicin—pancreatic cancer	0.000301	0.000301	CcSEcCtD
Valganciclovir—Abdominal pain—Epirubicin—pancreatic cancer	0.000301	0.000301	CcSEcCtD
Valganciclovir—Body temperature increased—Epirubicin—pancreatic cancer	0.000301	0.000301	CcSEcCtD
Valganciclovir—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00029	0.00029	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000288	0.000288	CcSEcCtD
Valganciclovir—Hypersensitivity—Epirubicin—pancreatic cancer	0.000281	0.000281	CcSEcCtD
Valganciclovir—Urticaria—Doxorubicin—pancreatic cancer	0.00028	0.00028	CcSEcCtD
Valganciclovir—Abdominal pain—Doxorubicin—pancreatic cancer	0.000279	0.000279	CcSEcCtD
Valganciclovir—Body temperature increased—Doxorubicin—pancreatic cancer	0.000279	0.000279	CcSEcCtD
Valganciclovir—Asthenia—Epirubicin—pancreatic cancer	0.000273	0.000273	CcSEcCtD
Valganciclovir—Pruritus—Epirubicin—pancreatic cancer	0.000269	0.000269	CcSEcCtD
Valganciclovir—Diarrhoea—Epirubicin—pancreatic cancer	0.000261	0.000261	CcSEcCtD
Valganciclovir—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00026	0.00026	CcSEcCtD
Valganciclovir—Asthenia—Doxorubicin—pancreatic cancer	0.000253	0.000253	CcSEcCtD
Valganciclovir—Dizziness—Epirubicin—pancreatic cancer	0.000252	0.000252	CcSEcCtD
Valganciclovir—Pruritus—Doxorubicin—pancreatic cancer	0.000249	0.000249	CcSEcCtD
Valganciclovir—Vomiting—Epirubicin—pancreatic cancer	0.000242	0.000242	CcSEcCtD
Valganciclovir—Diarrhoea—Doxorubicin—pancreatic cancer	0.000241	0.000241	CcSEcCtD
Valganciclovir—Dermatitis—Epirubicin—pancreatic cancer	0.00024	0.00024	CcSEcCtD
Valganciclovir—Headache—Epirubicin—pancreatic cancer	0.000239	0.000239	CcSEcCtD
Valganciclovir—Dizziness—Doxorubicin—pancreatic cancer	0.000233	0.000233	CcSEcCtD
Valganciclovir—Nausea—Epirubicin—pancreatic cancer	0.000226	0.000226	CcSEcCtD
Valganciclovir—Vomiting—Doxorubicin—pancreatic cancer	0.000224	0.000224	CcSEcCtD
Valganciclovir—Dermatitis—Doxorubicin—pancreatic cancer	0.000222	0.000222	CcSEcCtD
Valganciclovir—Headache—Doxorubicin—pancreatic cancer	0.000221	0.000221	CcSEcCtD
Valganciclovir—Nausea—Doxorubicin—pancreatic cancer	0.000209	0.000209	CcSEcCtD
